A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells (Q46131239)

19 December 2017

title

A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells (English)

1 reference

19 December 2017

main subject

mesenchymal stem cell

1 reference

1 reference

19 December 2017

Jean-Jacques Fournié

1 reference

19 December 2017

author name string

Ludovic Martinet

1 reference

19 December 2017

Sandrine Fleury-Cappellesso

1 reference

19 December 2017

Mélanie Gadelorge

1 reference

19 December 2017

Gilles Dietrich

1 reference

19 December 2017

Rémy Poupot

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

19 December 2017

European Journal of Immunology

published in

1 reference

19 December 2017

volume

1 reference

19 December 2017

issue

1 reference

19 December 2017

page(s)

752-762

1 reference

19 December 2017

Non-peptide antigens activating human Vgamma9/Vdelta2 T lymphocytes.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Anti-lymphoma effect of gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

gammadelta T cells: a new frontier for immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Biology and clinical applications of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Engineering mesenchymal stem cells for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Interactions between human mesenchymal stem cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Immunoregulatory function of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Transcriptional profiling of gamma delta T cells identifies a role for vitamin D in the immunoregulation of the V gamma 9V delta 2 response to phosphate-containing ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Pharmacokinetics of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Prostaglandin E receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Prostaglandins as modulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Mesenchymal stem cells: properties and role in clinical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

The role of mesenchymal stem cells in haemopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

21 January 2018

Pure red cell aplasia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Synaptic transfer by human gamma delta T cells stimulated with soluble or cellular antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Interferon‐γ–Mediated Antiviral Immunity against Orthopoxvirus Infection Is Provided by γδ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct γδ and αβ T cell responses in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Multiple Sclerosis: Limited Diversity of the V?2-J?3 T-Cell Receptor in Chronic Active Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

Human gamma delta T cells induce dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

7 January 2021

Reciprocal stimulation of gammadelta T cells and dendritic cells during the anti-mycobacterial immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

7 January 2021

Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

7 January 2021

Gamma /delta T cells provide innate immunity against renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

7 January 2021

Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

7 January 2021

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

7 January 2021

TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

7 January 2021

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838812

7 January 2021

Identifiers

DOI

10.1002/EJI.200838812

1 reference

19 December 2017

1 reference

19 December 2017